Thursday, December 14, 2006

Uba Expresses Confidence on President Thabo Mbeki and Urges Civilized Discussions on South Africa’s Controversial AIDS Policy

Uba Expresses Confidence on President Thabo Mbeki and Urges Civilized Discussions on South Africa’s Controversial AIDS Policy

Economic Technologies’ Chairman & CEO, Jude E. Uba, today, in conveying his confidence in the leadership of President Thabo Mbeki to effectively respond to South Africa’s Aids crisis, urged all parties involved to exercise civility in the ongoing debate surrounding that country’s controversial HIV/AIDS policy.

Houston, TX (PRWEB) September 16, 2006

Economic Technologies’ Chairman & CEO, Jude E. Uba, today, in conveying his confidence in the leadership of President Thabo Mbeki to effectively respond to South Africa’s dire Aids crisis, urged all parties involved to exercise civility in the ongoing debate surrounding that country’s controversial HIV/AIDS policy.

The current all daggers drawn siege, with the South African government on one side and the UN (joined by many AIDS advocates) on the other, is increasingly counterproductive, seriously undermining efforts to attend to the estimated 5.5 million South Africans with HIV.

According Uba, intelligent thinking must prevail. “The government of Thabo Mbeki, and that of Nelson Mandela before him, have earned their leadership credentials and credibility. The almost miraculous socio-economic results they have made possible, since 1994, including declining crimes, stable economic expansion, progressive and better race relations and a stable environment for business growth, with a steely, uncompromising determination to do what is in the long-term best interest of all South Africans, speak volumes.”

“AIDS is a dangerous human affliction that must be fought with all tools at our disposal, and with the best collaborative efforts, not ridicule. No responsible government stays idle, while the people it swore to lead are stained and perished by a deadly virus or disease, meanwhile waiting for foreign assistance or cure to arrive. It must deploy every resources and special knowledge at its immediate disposal, with true and practical compassion for those infected. That is leadership,” Uba stated. “I am confident that the great people of South Africa will prevail, in their determination to defeat this menace.”

But success will require a new, brilliant approach that must deliver short and long-term solutions.

1.

HIV virus tends to coat itself with sugar, a defensive psychology that makes it rather difficult to develop an effective cure for. And it has a tendency to, with a rapid climb, quickly lock the infected victim’s natural virus-fighting immune system gate. Thus, for a person with an already weakened or compromised immune mechanism, this means a rapid and consistent progression from HIV to AIDS, and subsequently death. This leads to African diet behavior. African daily nutritional behavior and value is critically and consistently lacking in fruits, fresh (not overcooked) vegetables and such well-known antioxidants as garlic. The result is a poor immune system. Thus, it clearly makes preventive sense to, aggressively, encourage the affordability and consistent consumption of these well-known immune boosting machinations, but not as a cure.

2.

Even if the government meets its current target of distributing Anti-Retroviral drugs (ARVs) to 380,000 infected people (it is having difficulties meeting that target), that still leaves millions unattended to. Almost 90% of HIV carriers are often unaware that they are infected, which makes them the most potent and leading distribution agents for this deadly virus. Therefore, it makes all the sense in the world that the strongest emphasis must be leveled on HIV testing platforms. Clearly, a very ambitious, nationalized HIV testing policy is long overdue for South Africa. This begs for coordinated private/public sector collaboration.

3.

The South African government is clearly dispatched in its attempt, faced with limited resources, to balance the needs of the vast numbers of its citizens infected with this virus, one of the worst in the world, with the demands of protecting the rest of the population from further escalation. To meet this balance the government has taken to some policy guidelines that many AIDS advocates, among them the UN Special Envoy for AIDS in Africa, Mr. Stephen Lewis, call “immoral” and a product of the “lunatic fringe.” The government needs a much better reflection, representation and articulation of its AIDS policy to all South Africans and must endeavor to respond and speak to its infected citizens with broader compassion, not indifference. “Great nations and leaders are measured not by how they treat the strong and powerful, but by how they respond to the needs of the weakest members of the family.” “And the world must deplore, with grave disdain, any attempt to use this human crisis to undermine or discredit any government or country. Clear-headed dedication and proven solutions, not conflict making or unproven methods must prevail. This is a battle that must be won,” Uba concluded.

And many around the world are determined to help in that battle, including this firm. In addition to the company’s efforts to deploy its economic science breakthrough, Dimax/EXCAP (the Fluid Fence economic growth application), to more than 150 countries, it, in 2005, through its advanced healthcare component, Fulana, launched the world’s largest healthcare venture, a massive and ground-breaking global health ambition, with a corporate commitment to build, operate and manage 5300 advanced, high-tech, globally interconnected networks of health centers and clinics in 150 countries, with on-site/no-border pharmacies and an advanced telemedicine capability. Driven by one core objective: to deploy and deliver, by far, the most advanced healthcare infrastructure and economic growth technologies to far-reaching and most remote corners of the globe. Seven hundred and fifty (750) of these high-tech and revolutionary health centers, will be equipped and outfitted with the broadest vaccine development, diagnostic and treatment facilities, to engage in aggressive internal and contract HIV/AIDS, malaria, infectious diseases and human immunology R&D. To support this massive healthcare operation, the company, in partnership with university medical centers in 40 countries and with such great companies as GE, IBM and others is also bent on creating and managing the world's largest library of leading and innovative medicines, point-to-care procedures data hubs, research, immune support nutritional breakthroughs and telemedicine infrastructure and know-how, with blockbuster revolutionary and potent disease preventive and management programs.

Also, two months ago, Economic Technologies announced its commitment to invest up to $100 million towards the development and marketing of affordable, 99% reliable, pregnancy test-like, HIV/AIDS personal testing kit, with reliable results in five minutes or less.

About Economic Technologies, Inc.

Economic Technologies is an advanced economic science and technology company, whose operational focus includes advanced economic systems, global healthcare, technologically advanced infrastructure solutions and economic intelligence+logistics. The company is leading an ambitious global effort, driven by innovative ideas and products, to help countries achieve massive and sustained economic growth, through the seamless convergence of breakthrough economic growth technologies and applications, advanced global healthcare access, brilliant infrastructure solutions and massive data distribution/delivery platforms. The Company’s proprietary economic science breakthrough, Dimax/EXCAP, the product of a 15-year intensive R&D, the first-of-its-kind, is changing how an estimated 4.5 billion people, worldwide, work and live.

###